US FDA declines to approve Merck’s chronic cough drug

(Reuters) – The U.S. Food and Drug Administration has declined to approve Merck’s drug for chronic cough, the company said on Wednesday.

(Reporting by Christy Santhosh, Khushi Mandowara and Sriparna Roy in Bengaluru; Editing by Tasim Zahid)